RE: Great company, excellent products, superb prospects27 Jan 2021 07:57
See below just to give new investors some realism
GDR already have the CE approval for 96 SARS-CoV-2 kit (still no sales worthy of an RNS)
- UK and European market accessible
In approval process with other regulators around the world
- South Africa now approved - market accessible (Been accessable for 3 months - no sales)
- US Approval - Emergency Use Authorisation (EUA) in progress with FDA (applied for 6 months ago)
- Biden kickstarting the US battle against COVID (read deploying funds) (yes hoping something will come from BC with this)
- India - Approval in progress (was VERY VERY NEAR almost 2 months ago - something wrong?)
- POC System - looking like another best in class proposition (still an oppurtunity)
Company itself well funded (money taken from investors at 80p with promise of sales in june - share price now below 50p)
UK Govt alone pumping £43bn into Covid testing (Uk goverment not target market and CE marked with no sales in UK)
- With 758mil already allocated to home testing
As other govts start launching initiatives like the US and UK the demand for tests will far outstrip supply.
The potential in this company is more than a little exceptional (potential yes not exceptional)
GLA - DYOR